Global Transplant Diagnostics Market Information, Product & Service (Instruments, Reagents & Consumables), Screening Type (Pre-Transplant, Post-Transplant), Organ Type (Kidney, Liver, Heart, Lung, Pancreas), Application Type, End-User – Forecast to 2023

  • Product Code:
    RP-ID-10077870
  • Published Date:
    Mar 2019
  • Region:
    Global
  • Pages:
    215
  • Category:
    Healthcare & Pharmaceuticals
  • Publisher:
    Market Research Future
Introduction
Transplant diagnostic is a test which is performed during organ transplantation to identify the compatibility of the organ. It is a medical procedure in which an organ is removed from one body and placed in another to swap the damaged or missing organ. The transplant diagnostic test is mainly performed to reduce the risk of organ rejection. Organ transplantation is performed to treat organ failures such as lungs, liver, kidney, and many more. The rising incidence of chronic and infectious diseases, increasing awareness related to transplant diagnostic procedures, and growing number of stem cell, soft-tissue, and solid organ transplantations are projected to drive market growth over the forecast period.
However, strict regulatory bodies and stringent regulatory policies are expected to restrain market growth during the forecast period.
The global transplant diagnostics market has been segmented, by product and service, screening type, organ type, application type, and end user.
Based on product and service, the global transplant diagnostics market has been categorized as instruments, reagents and consumables, and software and services.
On the basis of screening type, the global transplant diagnostics market is further sub-segmented into pre-transplant screening and post-transplant screening.
By organ type, the global transplant diagnostics market is further sub-segmented into kidney, liver, heart, lung, pancreas, and others.
On the basis of application type, the global transplant diagnostics market is further sub-segmented into research application, diagnostics applications, and others.
On the basis of end user, the market has been classified as commercial services providers, hospitals and transplant centers, research laboratories, and academics institutes and others
The global transplant diagnostics market was valued at USD 1,326.4 million in 2017 and is expected to register a CAGR of 7.81% during the forecast period from 2018 to 2023.
Key Players
Some of the key players in the global transplant diagnostics market are Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc, F. Hoffmann-La Roche AG, Qiagen N.V, BioMérieux SA, Illumina, Inc, Becton, Dickinson and Company, Caredx, Inc, Gendx, Zimmer Biomet, Medtronic PLC, DiaSorin S.P.A, Merck KGaA, and Immucor, Inc.
Objectives of the Study
• To provide a detailed analysis of the market structure along with a forecast of various segments and sub-segments of the global transplant diagnostics market
• To provide insights into factors influencing and affecting market growth
• To provide historical and forecast revenue of market segments and sub-segments with respect to countries
• To provide strategic profiling of key players in the market and comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market
• To provide economic factors that influence the global transplant diagnostics market
• To provide a detailed analysis of the value chain and supply chain of the global transplant diagnostics market
Target Audience
• Research and Development (R&D) Companies
• Academic Institutes and Universities
• Pharmaceutical Companies
• Raw Material Suppliers
• Suppliers and Distributors
• Transplant Diagnostics Kits Manufacturers
• Government
• Potential Investors

Key Findings
• The global transplant diagnostics market is expected to reach USD 2,074.7 million by 2023 at a CAGR of 7.81% from 2018 to 2023
• Based on products and services, the reagents and consumables segment holds the largest market share and is expected to reach USD 1,027.54 million by 2023 at a CAGR of 8.4% from 2018 to 2023
• The market in the Americas is expected to account for the largest share of the global transplant diagnostics market and is projected to reach USD 666.78 million by 2023
• The transplant diagnostics market in Asia-Pacific is projected to be the fastest-growing at a CAGR of 8.52% from 2018 to 2023
Regional Analysis
• Americas
o North America
 US
 Canada
o Latin America
• Europe
o Western Europe
 Germany
 France
 UK
 Italy
 Spain
 Rest of Western Europe
o Eastern Europe
• Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o Rest of Asia-Pacific
• Middle East & Africa
o Middle East
o Africa
Table of Contents:

1 Report Prologue
2 Executive Summary
3 Market Introduction
3.1 Scope of Study
3.2 Research Objective
3.3 List of Assumptions
3.4 Market Structure
4 Research Methodology
4.1 Primary Research Methodology
4.2 Data points received from the Specialist Doctors:
4.3 Data points received from the Manufacturer/ Pharmaceutical Companies:
4.4 Data points received from Hospitals, Diagnostic Centers:
4.5 Secondary Research Methodology
4.6 Market Share Analysis
4.7 Trade Analysis
4.8 Market Pricing Approach
4.9 Forecast Model
5 Market Dynamics
5.1 Introduction
5.2 Drivers
5.2.1 Growing number of stem cell, soft-tissue, and solid organ, transplantation procedures
5.2.2 Rising occurrence of chronic and infectious diseases
5.2.3 Increasing Awareness Related to Transplant Diagnostic Procedures
5.3 Restraints
5.3.1 Shortage of donor organ and limited medical reimbursement
5.3.2 High cost of NGS- and PCR-based devices
5.4 Opportunities
5.4.1 High demand for tissue engineering in cosmetic and reconstructive surgery
5.4.2 Growing geriatric population presents a significant growth opportunity
6 Market Factor Analysis
6.1 Porters Five Forces Analysis
6.1.1 Bargaining Power of Suppliers
6.1.2 Bargaining Power of Buyers
6.1.3 Threat of New Entrants
6.1.4 Threat of Substitutes
6.1.5 Intensity of Rivalry
6.2 Supply Chain Analysis
6.2.1 Primary activities
6.2.2 Secondary Activities
7 Immunosuppressant Drug Monitoring (ISD)
7.1 Overview
7.1 Diagnostic Tests for Transplantation
7.1.1 Therapeutic Drug Monitoring During Transplantation
7.2 Americas
7.2.1 North America
7.2.1.1 U.S.
7.2.1.2 Canada
7.2.2 South America
7.3 Europe
7.3.1 Germany
7.3.2 U.K
7.3.3 France
7.3.4 Spain
7.3.5 Italy
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Australia
7.4.5 Rest of Asia Pacific
7.5 Middle East & Africa
7.5.1 Middle East
7.5.2 Africa
8 Global Transplant Diagnostics Market, By Products and Services
8.1 Introduction
8.1.1 Instruments
8.1.2 Reagents & Consumables
8.1.3 Software and Services
9 Global Transplant Diagnostics Market, By Screening Type
9.1 Introduction
9.1.1 Pre-Transplant Screening
9.1.2 Post-Transplant Screening
10 Global Transplant Diagnostics Market, By Organ Type
10.1 Introduction
10.1.1 Kidney
10.1.2 Liver
10.1.3 Heart
10.1.4 Lung
10.1.5 Pancreas
11 Global Transplant Diagnostics Market, By Application Type
11.1 Introduction
11.1.1 Research Applications
11.1.2 Diagnostic Applications
12 Global Transplant Diagnostics Market, By End User
12.1 Introduction
12.1.1 Commercial Service Providers
12.1.2 Hospitals and Transplant Centres
12.1.3 Research Laboratories and Academic Institutes
13 Global Transplant Diagnostics Market, By Region
13.1 Introduction
13.2 Americas
13.2.1 North America
13.2.1.1 U.S.
13.2.1.2 Canada
13.2.2 South America
13.3 Europe
13.3.1 Germany
13.3.2 U.K
13.3.3 France
13.3.4 Spain
13.3.5 Italy
13.3.6 Rest of Europe
13.4 Asia Pacific
13.4.1 China
13.4.2 Japan
13.4.3 India
13.4.4 Australia
13.4.5 Rest of Asia Pacific
13.5 Middle East & Africa
13.5.1 Middle East
13.5.2 Africa
14 Competitive Landscape
14.1 Company Market Share Analysis
14.1.1 Introduction
14.2 Competitive Landscape
14.2.1 Introduction
14.3 Key Developments
15 Company Profiles
15.1 Thermo Fisher Scientific Inc.
15.1.1 Company Overview
15.1.2 Financial Overview
15.1.3 Products Offering
15.1.4 Key Developments
15.1.5 SWOT Analysis
15.1.6 Key Strategy
15.2 Bio-Rad Laboratories, Inc.
15.2.1 Company Overview
15.2.2 Financial Overview
15.2.3 Products Offering
15.2.4 Key Developments
15.2.5 SWOT Analysis
15.2.6 Key Strategy
15.3 F. Hoffmann-La Roche AG
15.3.1 Company Overview
15.3.2 Financial Overview
15.3.3 Products Offering
15.3.4 Key Developments
15.3.5 SWOT Analysis
15.3.6 Key Strategy
15.4 Qiagen N.V.
15.4.1 Company Overview
15.4.2 Financial Overview
15.4.3 Products Offering
15.4.4 Key Developments
15.4.5 SWOT Analysis
15.4.6 Key strategy
15.5 BioMérieux SA
15.5.1 Company Overview
15.5.2 Financial Overview
15.5.3 Products Offering
15.5.4 Key Developments
15.5.5 SWOT Analysis
15.5.6 Key Strategy
15.6 Illumina, Inc.
15.6.1 Company Overview
15.6.2 Financial Overview
15.6.3 Products Offering
15.6.4 Key Developments
15.6.5 SWOT Analysis
15.6.6 Key Strategy
15.7 Becton, Dickinson and Company
15.7.1 Company Overview
15.7.2 Financial Overview
15.7.3 Products Offering
15.7.4 Key Developments
15.7.5 SWOT Analysis
15.7.6 Key Strategy
15.8 Caredx, Inc.
15.8.1 Company Overview
15.8.2 Financial Overview
15.8.3 Products Offering
15.8.4 Key Developments
15.8.5 SWOT Analysis
15.8.6 Key Strategy
15.9 Gendx
15.9.1 Company Overview
15.9.2 Financial Overview
15.9.3 Products Offering
15.9.4 Key Developments
15.9.5 SWOT Analysis
15.9.6 Key Strategy
15.1 Zimmer Biomet
15.10.1 Company Overview
15.10.2 Financial Overview
15.10.3 Products Offering
15.10.4 Key Developments
15.10.5 SWOT Analysis
15.10.6 Key Strategy
15.11 Medtronic PLC
15.11.1 Company Overview
15.11.2 Financial Overview
15.11.3 Products Offering
15.11.4 Key Developments
15.11.5 SWOT Analysis
15.11.6 Key Strategy
15.12 DiaSorin S.P.A
15.12.1 Company Overview
15.12.2 Financial Overview
15.12.3 Products Offering
15.12.4 Key Developments
15.12.5 SWOT Analysis
15.12.6 Key Strategy
15.13 Merck KGaA
15.13.1 Company Overview
15.13.2 Financial Overview
15.13.3 Products Offering
15.13.4 Key Developments
15.13.5 SWOT Analysis
15.13.6 Key Strategy
15.14 Immucor, Inc.
15.14.1 Company Overview
15.14.2 Financial Overview:
15.14.3 Products Offering
15.14.4 Key Developments
15.14.5 SWOT Analysis
15.14.6 Key strategy
16 Appendix
16.1 Discussion Blue Print
16.2 Reference
Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report
Thermo Fisher Scientific Inc.

Bio-Rad Laboratories, Inc.

F. Hoffmann-La Roche AG

Qiagen N.V.

BioMérieux SA

Illumina, Inc.

Becton, Dickinson and Company

Caredx, Inc.

Gendx

Zimmer Biomet

Medtronic PLC

DiaSorin S.P.A

Merck KGaA

Immucor, Inc.
Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports